Ko et al. also demonstrated that the VDAC1-associated gene signature is a robust predictive biomarker of recurrence-free survival in breast, colon, and lung cancers, and that it is independent of standard clinical and pathological prognostic factors [34]. The gene discussed is VDAC1; the disease is lung cancer.